Inhibikase Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

인히비케이즈 테라퓨틱스NASDAQ:IKT · Nasdaq · Healthcare · sector #16

$1.98-1.00%

2026-10-06 close · prelim

Inhibikase Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$29M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy